ReviewFrontiers in oncology2026
Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Upper tract urothelial carcinoma (UTUC) is a relatively rare but aggressive malignancy. Accurate preoperative assessment of tumor grade, invasiveness, and prognosis remains challenging using conventional imaging, cytology, and ureteroscopic biopsy alone. Radiomics and deep learning may provide noninvasive tools for improving risk stratification and clinical decision-making. Methods: This narrative review summarizes current evidence on radiomics, machine learning, and deep learning in UTUC. Relevant studies were identified from PubMed, Web of Science, and Scopus and synthesized according to clinical applications and methodological considerations. Results: Radiomics and deep learning models have shown promising performance in pathological grade prediction, differentiation between UTUC and renal cell carcinoma, muscle invasion assessment, and survival or recurrence risk stratification. However, most studies remain retrospective, single-center, and limited by small sample sizes, heterogeneous imaging protocols, inconsistent segmentation methods, insufficient external validation, and limited evidence of clinical utility. Conclusion: Radiomics and deep learning are promising approaches for noninvasive preoperative risk stratification in UTUC. Future studies should focus on methodological standardization, multicenter external validation, prospective evaluation, model interpretability, and demonstration of incremental clinical benefit before routine clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.